NCT00445042
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Methodist Hospital - Baylor College of Medicine Houston, Texas, United States
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT00448149
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- The Methodist Hospital Research Institute Houston, Texas, United States
Completed
Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer
NCT00445523
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Baylor College of Medicine - Methodist Hospital Houston, Texas, United States
NCT00446368
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Baylor College of Medicine - Methodist Hospital Houston, Texas, United States
NCT01062178
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
NCT02370290
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT00303732
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Duke Comprehensive Cancer Center Durham, North Carolina, United States
NCT00227760
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- London Regional Cancer Program London, Ontario, Canada
NCT01014065
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
- Locations
-
- University of Alberta/ Cross Cancer Institute Edmonton, Alberta, Canada
NCT00334282
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- GSK Investigational Site Capital Federal, Buenos Aires, Argentina
- GSK Investigational Site Córdoba, Córdoba Province, Argentina
- GSK Investigational Site Rosario, Santa Fe Province, Argentina
- GSK Investigational Site Quilmes, Argentina